🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Welcome to CityTx! We announce our launch today w/ a mission to build the leading next-generation RNAi therapeutics company, unlocking RNAi’s transformative potential to help patients with a wide range of diseases. Learn more: citytx.com/news/city-ther…

Welcome to City, Andy Orth! We’re happy to share Andy’s appointment as CEO, bringing over 25 years of industry leadership experience. We’re excited to leverage Andy’s expert leadership to guide our success and operational excellence. Read more: businesswire.com/news/home/2025…

We’ve partnered with Bausch and Lomb  to develop a novel therapy for #retinaldiseases like #geographicatrophy. We’re excited to enable our shared vision of expanding the reach of RNAi-based medicines and make a meaningful impact. citytx.com/news/city-ther…

We’re heading to San Francisco for the JP Morgan Healthcare Conference. The team is excited to be on the ground with fellow industry leaders, innovators, and collaborators at #JPM25 this week - see you there!

City's Executive Chair, @jmaraganore, sat down with @BiotechTVHQ's @BradLoncar at NYSE to break down his outlook in biotech this year and the power of our approach to #RNAi. Check it out below.

Excited to welcome Baisong Mei, M.D., Ph.D., as CMO, Anna O’Driscoll as CHRO, and Sara Nochur, Ph.D., as an independent board member! Their expertise in life sciences will help drive our next phase of growth. Learn more below and at: businesswire.com/news/home/2025…

Exciting news from City! We’ve partnered with Biogen to develop select novel RNAi-based therapies leveraging our next-generation RNAi engineering technologies. Learn more: globenewswire.com/news-release/2…